Aspirin/Nicotinic Acid

阿司匹林/烟酸

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Nicotinic Acid
Drug Alias NameAspirin/Niacin烟酸/乙酰水杨酸烟酸阿司匹林acetylsalicylic acid/Nicotinic Acid阿司匹林烟酸 +[12
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsHydroxycarboxylic acid receptor 2 agonistsHM74 nicotinic acid GPCR agonists
TargetsCyclooxygenasesHydroxycarboxylic acid receptor 2HM74 nicotinic acid GPCR
Therapy Area/IndicationsDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AspirinNicotinic Acid
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCerenis Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCerenis Therapeutics Sa
Active IndicationsN/A
Inactive IndicationsDyslipidemias

Other Information

ATC CodeN/A
Related LinksN/A